<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04931004</url>
  </required_header>
  <id_info>
    <org_study_id>Pro2020003236</org_study_id>
    <nct_id>NCT04931004</nct_id>
  </id_info>
  <brief_title>Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection</brief_title>
  <official_title>Effect of Oral Hygiene Products on Reducing Expelled/Exhaled SARS-CoV-2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Colgate Palmolive</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Leicester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, cross-sectional study evaluating the effect of commercially available&#xD;
      mouthwashes on expelled/exhaled SARS-CoV-2 viral load using face mask sampling.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will consist of a Control Phase to optimize procedures for measuring&#xD;
      expelled/exhaled viral load, and a Evaluation phase comparing different commercially&#xD;
      available mouthwashes.&#xD;
&#xD;
      In the Control Phase. up to 20 COVID-19 patients will be asked to undergo a sequence of face&#xD;
      mask sampling and saliva collections prior to and after an oral rinse with (i) water and (ii)&#xD;
      a commercially-available cetylpyridinium chloride (CPC) mouthwash.&#xD;
&#xD;
      Based on outcomes of the Control Phase, the study will proceed into the Evaluation Phase,&#xD;
      which will randomize approximately 40 COVID-19 patients to receive 1 of 4 commercially&#xD;
      available Colgate mouthwashes following standard package instructions. Face mask sampling and&#xD;
      saliva will be collected prior to and after the mouth rinse to assess impact on SARS-CoV-2&#xD;
      viral load.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants will be randomized to one of four arms. Type of mouthwash will not be disclosed to participant. Laboratory personnel and investigators performing the outcome measurements and analysis will be blinded to intervention.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Control Phase - Primary Endpoint</measure>
    <time_frame>Single timepoint, ~1 hour</time_frame>
    <description>Reduction in viral load by face mask sampling from pre-intervention to 0-15 with CPC versus water rinse control</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation Phase - Primary Endpoint</measure>
    <time_frame>Single timepoint, ~1.5 hours</time_frame>
    <description>Reduction in viral load by face mask sampling from pre-intervention to 45-60 minutes versus water rinse control</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation Phase - Secondary Endpoint</measure>
    <time_frame>Single timepoint, ~1 hour</time_frame>
    <description>Reduction in viral load by face mask sampling from pre-intervention to 0-15 and15-30 minutes of oral rinse products versus water rinse control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparative Saliva Reduction</measure>
    <time_frame>Single timepoint, ~1.5 hours</time_frame>
    <description>Reduction in viral load in saliva pre-intervention to 30 and 60 minutes post-intervention.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Influence of Speaking</measure>
    <time_frame>Single timepoint, ~1 hour</time_frame>
    <description>Difference in viral load by face mask sampling with speaking versus not speaking</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>0.075% Cetylpyridinium Chloride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>1.5% Hydrogen peroxide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Chlorhexidine gluconate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Water rinse</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control for impact on viral load changes from mechanical rinsing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mouthwash Product</intervention_name>
    <description>Commercially over-the-counter Colgate mouthwashes will be administered according to standard package instructions. Viral load will be measured prior to and after mouth rinse using serial face mask and saliva samples.</description>
    <arm_group_label>0.075% Cetylpyridinium Chloride</arm_group_label>
    <arm_group_label>1.5% Hydrogen peroxide</arm_group_label>
    <arm_group_label>Chlorhexidine gluconate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water rinse</intervention_name>
    <description>30-second water rinse will occur in the control group. Viral load will be measured prior to and after water rinse using serial face mask and saliva samples.</description>
    <arm_group_label>Water rinse</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age â‰¥ 18&#xD;
&#xD;
          2. Able to provide consent&#xD;
&#xD;
          3. Polymerase chain reaction (PCR)-confirmed SARS-CoV-2 within previous 48 hours.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Clinical contraindication or poor feasibility to complete study procedures&#xD;
&#xD;
          2. Unwilling or unable to produce saliva or face mask samples&#xD;
&#xD;
          3. Unable to produce at least 500 microliters of saliva.&#xD;
&#xD;
          4. Eaten within past 30 minutes&#xD;
&#xD;
          5. Known allergy to mouthwash products&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yingda L Xie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Alland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Padmapriya Banada, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yingda L Xie, MD</last_name>
    <phone>9739722246</phone>
    <email>yingda.xie@rutgers.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Alland, MD</last_name>
    <email>allandda@njms.rutgers.edu</email>
  </overall_contact_backup>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>June 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>June 17, 2021</last_update_submitted>
  <last_update_submitted_qc>June 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Yingda Linda Xie, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices)</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Beginning 3 months and ending 5 years following article publication</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

